Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The mRNA for the Duffy blood group antigen, the erythrocyte receptor for the Plasmodium vivax malaria parasite, has recently been cloned and shown to encode a widely expressed chemokine receptor. Here, we show that the Duffy antigen/chemokine receptor gene (DARC) is composed of a single exon and that most Duffy-negative blacks carry a silent FY*B allele with a single T to C substitution at nucleotide -46. This mutation impairs the promoter activity in erythroid cells by disrupting a binding site for the GATA1 erythroid transcription factor. With the recent characterization of the FY*A and FY*B alleles, these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid-specific repression of the DARC gene in Duffy-negative individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DARC is an atypical chemokine receptor and the antigen of the Duffy (Fy) blood group system (Tournamille et al., 1995; Tournamille et al., 1998; Wasniowska and Hadley, 1994).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
In the citing paper
“A substantial part of the human population carries a homozygous mutation (FY*AES or FY*BES alleles for erythrocyte silent) in the erythroid-specific promoter of the FY gene, resulting in a lack of expression of the receptor on erythrocytes (Fya−/b− phenotype) but not in non-erythroid tissues (Tournamille et al., 1995; Zimmerman et al., 1999).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
Citations
Cites
Luckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
The Resistance Factor to Plasmodium vivax in Blacks: The Duffy-Blood-Group Genotype,FyFy
Miller, L. H., Mason, S. J., Clyde, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,260
Race, R. R., & Sanger, R. A. (1962) · Medical Entomology and Zoology · Cited by 1,162
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 914
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884
Erythrocyte Receptors for ( Plasmodium Knowlesi ) Malaria: Duffy Blood Group Determinants
Miller, L. H., Mason, S. J., Dvorak, J. A., McGinniss, M. H., & Rothman, I. K. (1975) · Science · doi:10.1126/science.1145213 · Cited by 610
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hébert, C. A., Valente, A. J., & Baker, J. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115442 · Cited by 452
Globin gene regulation and switching: Circa 1990
Orkin, S. H. (1990) · Cell · doi:10.1016/0092-8674(90)90133-y · Cited by 442
Chitnis, C. E., & Miller, L. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.497 · Cited by 426
Research works printed but not linked: 1
- Toumamilte, C., Le Van Kim, C., Gane, P., Cartron, J.P. & Colin, Y. Molecular basis and PCR-DNA typing of the Pya/Pyb blood group polymorphism. Hum. Genet. 85, 407–410 (1995).
Cited by
Items 501–600 of 742
O desafio da malária: o caso brasileiro e o que se pode esperar dos progressos da era genômica
da Silva, L. P., & de Oliveira, V. E. G. (2002) · Ciência & Saúde Coletiva · doi:10.1590/s1413-81232002000100005 · Cited by 20
The red cell chemokine receptor is distinct from the Fy6 epitope
Hausman, E., Dzik, W., & Blanchard, D. (1996) · Transfusion · doi:10.1046/j.1537-2995.1996.36596282585.x · Cited by 8
Daniels, G. L. (2013) · Wiley eBooks · doi:10.1002/9781118493595.ch8 · Cited by 8
Abebe, A., Dieng, C. C., Dugassa, S., Abera, D., Shenkutie, T. T., Assefa, A., Ménard, D., Lo, E. Y. Y., & Golassa, L. (2024) · Malaria Journal · doi:10.1186/s12936-024-04887-1 · Cited by 7
Wu, P. C., McGowan, E. C., Lee, Y. Q., Ghosh, S., Hansson, J., & Olsson, M. L. (2024) · Transfusion · doi:10.1111/trf.17840 · Cited by 6
“9 GATA1 has also been shown to drive expression in XG and KN systems.”
BackgroundBlood groups: genetics and physiology
Cartron, J. (2010) · ISBT Science Series · doi:10.1111/j.1751-2824.2010.01388.x · Cited by 9
Self-citationHuman Genetics of Infectious Diseases
Alcaïs, A., & Casanova, J. (2009) · Springer eBooks · doi:10.1007/978-3-540-37654-5_14 · Cited by 8
Duffy blood system and G6PD genetic variants in vivax malaria patients from Manaus, Amazonas, Brazil
Ferreira, N. S., Mathias, J. L. D. S., Albuquerque, S. R. L., de Almeida, A. C. G., Dantas, A. C., Anselmo, F. C., Lima, É. S., Lacerda, M., Nogueira, P. A., Ramasawmy, R., et al. (2022) · Malaria Journal · doi:10.1186/s12936-022-04165-y · Cited by 10
“01) bear the Fy(a−b−) phenotype that is known to be a protective factor against vivax malaria infections [15].”
BackgroundBlood Grouping Based on PCR Methods and Agarose Gel Electrophoresis
Sell, A. M., & Visentainer, J. E. L. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2690-9_4 · Cited by 7
The Duffy Blood Group System and Its Extensions in Nonhuman Primates
Pogo, A. O., & Chaudhuri, A. (1997) · Springer eBooks · doi:10.1007/978-3-642-59086-3_7 · Cited by 7
Hernández‐Romano, J., Martínez-Barnetche, J., & Valverde-Garduño, V. (2009) · Salud Pública de México · doi:10.1590/s0036-36342009000900011 · Cited by 7
The future role of molecular and cell biology in medical practice in the tropical countries
Weatherall, D. J. (1998) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011703 · Cited by 7
Blood groups on red cells, platelets and neutrophils
Daniels, G. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3147-2.00037-7 · Cited by 8
Wagner, F. F., Flegel, W. A., Bittner, R., & Döscher, A. (2016) · British Journal of Haematology · doi:10.1111/bjh.14469 · Cited by 7
“Additional alleles, such as FY*02N.01 (Storry et al, 2014) with a GATA box mutation (Tournamille et al, 1995; Schmid et al, 2012) should be added in the future along with other clinically relevant blood group systems.”
BackgroundLee, Y. Q., Storry, J. R., Crew, V. K., Halverson, G. R., Thornton, N. M., & Olsson, M. L. (2019) · Transfusion · doi:10.1111/trf.15242 · Cited by 7
“Despite the apparent lack of Fy antigen on their RBCs they do not make anti-Fy because the phenotype is due to the loss of an upstream GATA motif.(17) Expression of Xg glycoprotein in nonerythroid cells in the bone marrow or other tissues may thus explain why Xg(a−) persons carrying at least one intact XG coding regio…”
BackgroundMózner, O., Zámbó, B., & Sarkadi, B. (2021) · Membranes · doi:10.3390/membranes11080586 · Cited by 7
“Interestingly, a similar role of a polymorphic GATA1 binding site in the promoter region has been documented in modulating the expression of the Duffy blood group antigen, a receptor for Plasmodium in erythroid cells, thus reducing malaria infection [16].”
BackgroundWalters, J., Binkley, E. M., Haygood, R., & Romano, L. A. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.01.007 · Cited by 8
“, 2004), and resistance to malarial infection in humans (Tournamille et al., 1995).”
BackgroundALLISON, A. C. (2008) · Public Health Genomics · doi:10.1159/000154817 · Cited by 7
Hemoglobinas humanas: hipótese malária ou efeito materno?
Torres, F. R., & Bonini-Domingos, C. R. (2005) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842005000100013 · Cited by 7
Duffy antigen inhibitors: useful therapeutics for malaria?
Handel, T. M., & Horuk, R. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.03.010 · Cited by 6
Affinity-optimizing variants within the ZRS enhancer disrupt limb developmentPreprint
Lim, F., Ryan, G. E., Le, S. H., Solvason, J. J., Steffen, P., & Farley, E. (2022) · bioRxiv · doi:10.1101/2022.05.27.493789 · Cited by 7
“A SNV within an enhancer for the membrane protein Duffy is associated with malarial resistance (Tournamille et al., 1995).”
BackgroundBouyssou, I., Martínez, F. J. M., Campagne, P., Ma, L., Doderer-Lang, C., Chitnis, C. E., & Ménard, D. (2022) · Comptes Rendus Biologies · doi:10.5802/crbiol.95 · Cited by 7
Clinical associations with a polygenic predisposition to benign lower white blood cell counts
Mosley, J. D., Shelley, J. P., Dickson, A. L., Zanussi, J., Daniel, L. L., Zheng, N. S., Bastarache, L. A., Wei, W., Shi, M., Jarvik, G. P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47804-5 · Cited by 7
“…variation associated with benign biomarker variation to systematically disadvantage an identi fi able subset of individuals is exempli fi ed by the rs2814778-CC genotype, which is predominantly carried by individualsofAfrican ancestry and underlies the clinical phenomenon of benign neutropenia 22 .”
BackgroundMolecular blood group screening in Omani blood donors
Al‐Riyami, A. Z., Hinai, D. A., Al‐Rawahi, M., Al‐Hosni, S., Al‐Zadjali, S., Al‐Marhoobi, A., Al-Khabori, M. K., Al‐Riyami, H., & Denomme, G. A. (2021) · Vox Sanguinis · doi:10.1111/vox.13204 · Cited by 6
“The Fy(a-b-) phenotype is common among the African population [26], and found at a greater than 80% in African Americans and more than 95% of West Africans [27].”
BackgroundThe Complexity of the Host Genetic Contribution to the Human Response to Mycobacterium leprae
Fava, V. M., & Schurr, E. (2016) · doi:10.1489/itl.8.1 · Cited by 7
Is There a Genetic Basis for Health Disparities in Human Immunodeficiency Virus Disease?
Winkler, C. A. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20172 · Cited by 6
Opoku-Okrah, C., Gordge, M. P., Nakua, E. K., Abgenyega, T., Parry, M., Robertson, C. E., & Smith, C. L. (2013) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12122 · Cited by 8
Studies of a Murine Monoclonal Antibody Directed against DARC: Reappraisal of Its Specificity
Smolarek, D., Hattab, C., Buczkowska, A., Kaczmarek, R., Jarząb, A., Cochet, S., de Brevern, A. G., Łukasiewicz, J., Jachymek, W., Niedziela, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116472 · Cited by 6
“That phenotype, called Fy(a-b-) is caused by a single nucleotide polymorphism at position -67T>C in the GATA box of DARC gene promoter [1] and it was thought for decades that it was associated with resistance of red blood cells to infection by Plasmodium vivaxmerozoites [2].”
BackgroundSelf-citationMalta, M. C. F. D. S., Sales, C. C., Guimarães, J. C., Gonçalves, P. D. C., Chaves, D. G., Santos, H. C., Pereira, A. C., Ribas, J. G., Carneiro‐Proietti, A. B. F., & Martins, M. L. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000539 · Cited by 7
Susceptibility to infectious diseases
Walley, A. J., & Hill, A. V. S. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543555.020 · Cited by 6
Daniels, G. L. (2002) · Wiley eBooks · doi:10.1002/9780470987018.ch8 · Cited by 6
Zhang, R., Wen, J., Tang, C., Jia, S., Chen, Q., & Ji, Y. (2025) · Transfusion · doi:10.1111/trf.18223 · Cited by 5
“16 Recently, the variants of the GATA motif located in the regulatory elements of ABO intron 1 may lead to Bm and Am phenotypes with decreased expression of A and B antigens on RBCs. 17,18 Besides, one variant (c.1-115A>C) in the GATA-1 motif of the RHD promoter was also identified in one…”
Hibbs, S. P., Jones, J. M., Hantel, A., & Merz, L. E. (2025) · British Journal of Haematology · doi:10.1111/bjh.20258 · Cited by 6
A contribuição dos polimorfismos humanos do eritrócito na proteção contra a malária
Machado, P., Mendes, C., do Rosário, V. E., & Arez, A. P. (2010) · Revista Pan-Amazônica de Saúde · doi:10.5123/s2176-62232010000400013 · Cited by 13
A New Method for Analyzing the Duffy Blood Group Genotype by TaqMan Minor Groove Binding Probes
Zhou, S., Liu, M., An, W., Liang, X., Yu, W., & Piao, F. (2014) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21751 · Cited by 5
“This SNP disrupts the binding site for the GATA-1 erythroid transcription factor, abolishes erythroid expression of the FY*B in the erythroid lineage but not in other tissues (7,8).”
BackgroundŁukasik, E., Nowak, I., Czerwiński, M., & Waśniowska, K. (2019) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2018.12.020 · Cited by 6
Nepalese populations show no association between the distribution of malaria and protective alleles
Caetano, C. P., Kraaijenbrink, T., Tuladhar, N. M., van Driem, G. L., de Knijff, P., Tyler-Smith, C., & Carvalho‐Silva, D. (2006) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000020 · Cited by 5
“KEYWORDS: Malaria, Himalayas, Nepal, single nucleotide polymorphisms, selection, resistance”
BackgroundHuman Blood Group Antigens and Antibodies
Westhoff, C. M., Storry, J. R., & Shaz, B. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00110-4 · Cited by 5
Erickson, M. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-67509-3.00009-3 · Cited by 5
Haiyambo, D. H., Aleksenko, L., Mumbengegwi, D. R., Bock, R. D., Uusiku, P., Malleret, B., Rénia, L., & Quaye, I. K. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06573-y · Cited by 5
Eradication of malaria through genetic engineering: the current situation
Chong, W. C., Basir, R., & Fei, Y. M. (2013) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(13)60001-2 · Cited by 7
Reid, M. E., & Lomas, C. (2004) · Elsevier eBooks · doi:10.1016/b978-012586585-2/50011-1 · Cited by 5
Hemolytic disease of the fetus and newborn
Waldron, P. E., & Cashore, W. J. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545306.008 · Cited by 5
Plasmodium falciparum malaria and carbohydrate blood group evolution
Cserti-Gazdewich, C. M. (2010) · ISBT Science Series · doi:10.1111/j.1751-2824.2010.01380.x · Cited by 8
FY*A silencing by the GATA‐motif variant FY*A(−69C) in a Caucasian family
Pı́sačka, M., Marinov, I., Králová, M., Králová, J., Koranova, M., Bohoněk, M., Sood, C., & Ochoa‐Garay, G. (2015) · Transfusion · doi:10.1111/trf.13221 · Cited by 6
Anti‐Fy3 in sickle cell disease: a difficult transfusion problem
Went, R., Wright, J., Webster, R., & Stamps, R. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07494.x · Cited by 5
“We now know that this is because most Africans with Fy(a-b-) red cells have a structurally normal Fyb allele with a mutation in the GATA-1 site to which the erythroid transcription factor binds (Tournamille et al, 1995).”
BackgroundSheffield, W. P., Bhakta, V., Branch, D. R., & Denomme, G. A. (2006) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2006.09.003 · Cited by 5
“Two other genetic alterations result in quantitative, rather than qualitative variations in Fy expression: Fy (R89/91C) [11]; and FYA/FYB ( 33 T > C), a promoter mutation nullifying erythroid Fy expression in Blacks of West African ancestry [12] or Asians from Papau New Guinea [13].”
BackgroundRECENT INSIGHTS INTO THE POPULATION GENETICS AND DYNAMICS OF THE INHERITED DISORDERS OF HEMOGLOBIN
Weatherall, D. J. (2009) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2009.022 · Cited by 5
“This red cell phenotype results from a mutation in a GATA-1 binding site in the gene for the Duffy antigen chemokine receptor (DARC) which prevents its expression and hence the Duffy negative phenotype.(32)”
Membrane Blood Group Antigens and Antibodies
Reid, M. E., & Westhoff, C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06981-9.50010-7 · Cited by 5
Hemolytic disease of the fetus and newborn
Ross, M. E., Waldron, P. E., Cashore, W. J., & de Alarcón, P. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511978135.008 · Cited by 5
Daniels, G. L. (2017) · Wiley eBooks · doi:10.1002/9781119129431.ch3 · Cited by 5
Kranjc, A., Narwani, T., Abby, S. S., & de Brevern, A. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713280 · Cited by 5
“mutation in an erythroıd regulatory element site in the DARC promoter region [8].”
BackgroundImpact of transcription factors KLF1 and GATA1 on red blood cell antigen expression: a review
Lopez, G. H., Sarri, M. E., Flower, R. L., & Hyland, C. A. (2024) · Immunohematology · doi:10.2478/immunohematology-2024-002 · Cited by 7
Sullivan, J. C., Gleadall, N., & Lane, W. J. (2021) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2021.07.009 · Cited by 4
Genotyping and the Future of Transfusion in Sickle Cell Disease
Karafin, M. S., & Howard, J. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.07.012 · Cited by 6
Polymorphisms in the promoter regions of RHD and RHCE genes in the Chinese Han population
Shao, L., Zheng, Z., Zhou, S., Zhang, S., Song, W., Xia, Y., & Liang, X. (2023) · Vox Sanguinis · doi:10.1111/vox.13522 · Cited by 4
“In the Duffy blood group system, a mutation in the GATA-1 binding site of the Duffy gene ’ s promoter region results in the Duffy-null phenotype that prevents gene transcription in erythroid cells [14].”
BackgroundInflammatory risk contributes to post-COVID endothelial dysfunction through anti-ACKR1 autoantibody
Lee, E. S., Nguyen, N. L. U., Young, B. E., Wee, H. S.-A., Wazny, V. K., Lee, K. L., Tay, K. Y., Goh, L. L., Chioh, F. W., Law, M. C. Y., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402598 · Cited by 4
“Intriguingly, a single nucleotide polymorphism in the ACKR1 gene, affecting the binding of the GATA1 transcription factor to the gene promoter, hinders the expression of the Duffy antigen on erythrocytes but does not impact its ACKR1 expression on endothelial cells (32).”
BackgroundTinker where the tinkering's good
Rockman, M. V., & Stern, D. L. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.04.003 · Cited by 5
Duffy blood group system and ocular toxoplasmosis
Ferreira, A. I. C., Brandão, C. C., Frederico, F. B., Bernardo, C. R., de Almeida, G. C., Siqueira, R. C., Meira, C. D. S., Pereira‐Chioccola, V. L., & de Mattos, L. C. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104430 · Cited by 4
Human Genetic Factors as Determinants of Resistance to Malaria: A systematic Review
Fofana, B., Takala‐Harrison, S., Ouattara, A., & DJIMDÉ, A. A. (2023) · African Journal of Parasitology Mycology and Entomology · doi:10.35995/ajpme1010006 · Cited by 6
Molecular Basis of Erythrocyte Blood Group Antigens and Applications in Transfusion Medicine
Stony, J. R. (2002) · Vox Sanguinis · doi:10.1111/j.1423-0410.2002.tb05273.x · Cited by 5
The Duffy blood group system in the Tunisian population
Ouchari, M., Romdhane, H. B., Chakroun, T., Abdelkefi, S., Jarrey, I., Houissa, B., & Yacoub, S. (2015) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2015.03.002 · Cited by 5
Mirgal, D., Ghosh, K., Mahanta, J., Dutta, P., & Shetty, S. (2016) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trw026 · Cited by 4
Rh, Kell, Duffy, and Kidd Antigens and Antibodies
Westhoff, C. M., & Reid, M. E. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06981-9.50012-0 · Cited by 4
Blood Groups: Molecular Genetic Basis
Avent, N. D. (2018) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0006034.pub2 · Cited by 4
Groupes sanguins et relation structure-fonction
CARTRON, J. (1998) · Transfusion Clinique et Biologique · doi:10.1016/s1246-7820(98)80007-4 · Cited by 4
Self-citationPromoter polymorphisms in the JK*01 W.06 allele associated with the Jk(a + w) weak antigen phenotype
Liang, S., Wu, F., Jiang, R., Liu, T., Sun, L., Tang, R., Dang, Y., & Deng, Z. (2025) · BMC Immunology · doi:10.1186/s12865-025-00727-2 · Cited by 3
“Research has found that transcriptional regulation plays a crucial role in the expression of various blood group antigens on the surface of RBCs, including ABO [13], Duffy [14], Vel [15], and P1 [16].”
The emerging roles of ACKR1/Duffy antigen beyond malaria
Shaikh, R., Ghosh, K., & Gorakshakar, A. (2025) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2025.104255 · Cited by 3
Chen, T., Zhang, H., Mazumder, R., & Lin, X. (2026) · Nature Methods · doi:10.1038/s41592-026-03235-2 · Cited by 5
Rayner, J. C. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04518.x · Cited by 3
Antonangelo, A. T. B. F., Colombi, D., Curi, R. A., Braz, A. S. K., Oliveira, T. M. F. D. S., & da Mota, L. S. L. S. (2012) · Pesquisa Veterinária Brasileira · doi:10.1590/s0100-736x2012000900020 · Cited by 2
Srivastava, K., Fratzscher, A.-S., Lan, B., & Flegel, W. A. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04169-6 · Cited by 3
Langhi, D. M., Albuquerque, S. R. L., Serafim, R., Duarte, G. D. C., Covas, D. T., & Bordin, J. O. (2022) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0490-2021 · Cited by 4
When the available blood supply mismatches the needs of the patient.
Weidner, L., Allhoff, W., Pistorius, C., Witt, V., Rohde, E., Schistal, E., & Jungbauer, C. (2023) · PubMed Central · doi:10.2450/2022.0166-22 · Cited by 3
Ancestry, ACKR1 and leucopenia in patients with systemic lupus erythematosus
Chung, C. P., Karakoc, G., Liu, G., Gamboa, J. L., Mosley, J. D., Cox, N. J., Stein, C., & Kawai, V. K. (2022) · Lupus Science & Medicine · doi:10.1136/lupus-2022-000790 · Cited by 3
Susceptibility and Response to Infection
Murray, M. F. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00047-1 · Cited by 9
Immunohematology, Blood Groups
Fayyaz, K., & Westhoff, C. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00076-3 · Cited by 3
Chemokines and Chemokine Receptors in Infectious Disease
Cortez, K. J., Jackson, J. O., & Kottilil, S. (2005) · Current topics in membranes · doi:10.1016/s1063-5823(04)55011-1 · Cited by 3
Genomics of selected human odorant receptors
Knape, K., Beyer, A., Stary‐Weinzinger, A., Buchbauer, G., & Wolschann, P. (2008) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-008-0957-6 · Cited by 3
Kajumbula, H., Byarugaba, W., & Wayengera, M. (2012) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-10-8 · Cited by 3
“The same leads to impairment of the promoter activity in erythroid cells by disrupting a binding site for the GATA1 erythroid transcription factor [18], thereby resulting into RBC-resistance to invasion by P. vivax merozoites.”
Fichou, Y., Maréchal, C. L., Scotet, V., Jamet, D., & Férec, C. (2015) · Transfusion Medicine and Hemotherapy · doi:10.1159/000382086 · Cited by 3
Woolley, I. J., Hutchinson, P. E., Reeder, J. C., Kazura, J. W., & Cortés, A. (2009) · Immunohematology · doi:10.21307/immunohematology-2019-233 · Cited by 3
Hemolytic Disease of the Fetus and Newborn
Ross, M. E., Emery, S. P., de Alarcón, P. A., & Watchko, J. F. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108773584.011 · Cited by 3
The Atypical Chemokine Receptors
Singh, M. D., Nibbs, R. J. B., & Graham, G. J. (2010) · Methods and principles in medicinal chemistry · doi:10.1002/9783527631995.ch4 · Cited by 3
Krause, D. S., & Perkins, A. S. (1997) · Nature Medicine · doi:10.1038/nm0997-960 · Cited by 3
Susceptibility to Human Infectious Diseases, Genetics of
Kaslow, R. A., Shrestha, S., & Tang, J. ‘. (2008) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0020761 · Cited by 3
Evolutionary insights into duffy gene in mammalian taxa with comparative genetic analysis.
Awasthi, G., Dashb, A. P., & Dasa, A. (2009) · PubMed · Cited by 3
Klein, H. G., & Anstee, F. D. J. (2013) · Wiley eBooks · doi:10.1002/9781118689943.ch6 · Cited by 3
Daniels, G. L., & Stowell, S. R. (2022) · Wiley eBooks · doi:10.1002/9781119665885.ch3 · Cited by 3
Regulation of Blood Group Expression: Another Layer of Complexity to Consider
Gassner, C., & Olsson, M. L. (2024) · Transfusion Medicine and Hemotherapy · doi:10.1159/000539611 · Cited by 3
Aubé, S., Dubé, A. K., & Landry, C. R. (2026) · Nature Ecology & Evolution · doi:10.1038/s41559-026-03142-x · Cited by 3
“Multiple examples of adaptive single mutations in promoters have moreover been identified across bacteria 77–79 , yeast 80 and humans 15,16 , and sometimes even associated with decreased expression 15,16,78,80 .”
Manfroi, S., Scarcello, A., & Pagliaro, P. (2015) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2015.04.013 · Cited by 2
“knowlesi [1,3].”
Five novel FY null alleles associated with typing discrepancies
Vege, S., Floch, A., Lomas, C., Clarke, G., & Westhoff, C. M. (2021) · Transfusion · doi:10.1111/trf.16676 · Cited by 2
Haffener, P. E., Hopson, H. D., Herbert-Mainero, A., Ramirez, A., & Leffler, E. M. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013240 · Cited by 3
“In humans, a SNP in the GATA-1 transcription factor binding region upstream of the ACKR1 gene (previously known as DARC ) is associated with protection against P. vivax (rs2814778, -67 T > C) [39,40].”
Highly conserved Plasmodium vivax genomes in Duffy-negative individuals from Sudan
Schroeder, R. E., Ahmed, S., Ford, A., Elfaki, M. M. A., Hamad, S. O., Elfaki, T. M., Mohamed, S., Mańko, E., Clark, T. G., Campino, S. G., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-28797-7 · Cited by 2
Barnes, K. C., Grant, A. V., Hansel, N. N., Gao, P., & Dunston, G. M. (2012) · Proceedings of the American Thoracic Society · Cited by 2
Castilho, L. M., & Júnior, J. P. (2004) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842004000200012 · Cited by 2
Looking Beyond HEA: Matching SCD Patients for RH Variants
Reid, M. E., & Hipsky, C. H. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7512-6_10 · Cited by 2
“To minimize the chance of misinterpreting results obtained by testing DNA, it is important to include assays for nucleotide changes that are known to weaken or silence the expression of encoded antigens, especially for those that are prevalent, e.g., RHD*yD [37], FY*GATA [ 38 ], FY*265 [39–41], GYPB*230, and GYPB*-i5+…”
BackgroundAnsel, A., Lewis, J. D., Melnick, D. J., Martins, C. S., Valladares‐Pádua, C., & Perez‐Sweeney, B. (2017) · American Journal of Primatology · doi:10.1002/ajp.22690 · Cited by 2
Reid, M. E., Lomas, C., & Olsson, M. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415849-8.00010-7 · Cited by 2
Metadata
- Authors
- Tournamille, C., Colin, Y., Cartron, J. P., & Le Van Kim, C.
- Affiliations
- Inserm (FR)
- Venue
- Nature Genetics
- Published
- 1995-06
- Volume
- 10
- Issue
- 2
- Pages
- 224-228
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2080491517
- Cited by
- 741
- References
- 32
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 23 · 2023: 28 · 2022: 20 · 2021: 28 · 2020: 27 · 2019: 23 · 2018: 22 · 2017: 27 · 2016: 21 · 2015: 22 · 2014: 25 · 2013: 33 · 2012: 25
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- Duffy blood group system, promoter mutations, erythroid gene expression, Plasmodium vivax, chemokine receptors, single-exon genes, African Americans
- MeSH terms
- Antigens, Protozoan, Base Sequence, Carrier Proteins, Chromosome Mapping, DNA-Binding Proteins, Duffy Blood-Group System, Erythrocytes, Genotype, Humans, Molecular Sequence Data, Mutation, Promoter Regions, Genetic, Receptors, Cell Surface, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Protozoan Proteins, Gene Expression, Black People, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.